GSK US

11.1K posts

GSK US banner
GSK US

GSK US

@GSKUS

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://t.co/woIbYTUlEv

Philadelphia and RTP Katılım Mart 2009
974 Takip Edilen95.2K Takipçiler
GSK US
GSK US@GSKUS·
Hi, thanks for your message. We've received several reports about a recruitment scam circulating from hiring@careers-gsk.com for a Data Analyst role. We're actively investigating this, and we appreciate you bringing it to our attention. If you've received one of these emails, please help us by forwarding all relevant details and materials to askus@gsk.com. A reminder that GSK will never ask for payment at any stage of our recruitment process. Thank you for your support.
English
0
0
0
49
Shantanu singh
Shantanu singh@shIanAtaSnu·
@GSKUS Is hiring@careers-gsk.com a genuine email address used by GSK for recruitment in India?
English
2
0
0
87
GSK US
GSK US@GSKUS·
We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need. Check out our #AMR podcast: gsk.to/4rj3UUt
English
0
0
0
447
GSK US retweetledi
GSK
GSK@GSK·
Our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders. Take a look at the highlights ⤵️ 🔗 Investors and media can read more: gsk.to/4ubX9pQ
English
2
2
6
1.8K
GSK US
GSK US@GSKUS·
We’re on the ground at #AAAAI26, sharing our latest #RespiratoryHealth research this week. Stop by Booth 1137 to learn more. If you can’t attend, you can learn more about our work here: gsk.me/4tYOfvR 🫁
GSK US tweet media
English
0
0
2
390
長谷部💉接種者からBluetooth信号今も出てる⚠BLEスキャナー(アプリ)で実際に確認して‼️
@GSK @GSKcareers @GSKUS Strange elements like these have been detected in your company's "FluNase"! x.com/hasebetomoya1/…
長谷部💉接種者からBluetooth信号今も出てる⚠BLEスキャナー(アプリ)で実際に確認して‼️@hasebetomoya1

お疲れ様です。🙏 市販点鼻薬のフルナーゼ(ロットナンバーHP3D)を今日、某所のXRFで元素分析(先月ダイソーマスクを分析した所とは違う場所。今回のXRFの方が質が高い新式)したのですが、このような元素が⚠️⚠️🤯🤦‍♂️ 今まで色んな市販製品を元素分析してきましたが、間違いなくこのフルナーゼが一番強烈です。💦 ただ、製造しているグラクソ・スミスクラインは被害者多数のHPVワクチンやシングリックスを作ってる悪名高きビッグファーマですからね。まあ全然あり得る話なのかなと。🧐 念のため皆様にお伝えしておきますが、私はこの製品は全ロットがリコールされるべきと考えており、周りに働きかけています。 今回フルナーゼからXRFで検出された妙な元素 F フッ素 S 硫黄 Rb ルビジウム Sr ストロンチウム Y イットリウム Zr ジルコニウム Sb アンチモン Ba バリウム 以前、SEM-EDXで検出したと報告したテルルと臭素なのですけれども、大変申し上げ辛いのですがこれはちょっと機器の誤判定の公算が大きいと思われます。🙇‍♂️ SEM-EDXは基本的にあまり精度の高い機器ではないのです。。

English
1
1
9
304
GSK US retweetledi
GSK
GSK@GSK·
Explore the key highlights from our Q4 and full year 2025 results announcement ⤵️ More information for media and investors: gsk.to/4a2WXQw $GSK
English
1
1
6
1.6K
GSK US retweetledi
GSK
GSK@GSK·
Watch our CEO Luke Miels as he shares our strong 2025 performance and reaffirms our long-term outlooks. More insights and information for media and investors: gsk.to/4ti5YOs $GSK #FYResults
English
4
1
11
1.5K
GSK US
GSK US@GSKUS·
#News for #Media: Meet the Linked by Lupus: Optimal Care Initiative grant awardees; orgs working to improve early diagnosis, expand access to treatment, and strengthen patient-provider communications for those impacted by #lupus. Read more about the grant and awardees: gsk.to/3LRfTd4
GSK US tweet media
English
1
1
2
553
GSK US
GSK US@GSKUS·
We're leaving #JPM2026 inspired and confident in our R&D momentum & future pipeline impact. Our approach, built on cutting-edge innovation and industry-leading partnerships, is driving us to get ahead of disease together. #AheadTogether
GSK US tweet mediaGSK US tweet mediaGSK US tweet mediaGSK US tweet media
English
0
0
0
525
GSK US
GSK US@GSKUS·
We’re excited to announce Court Horncastle's selection as a Life Sciences Voice Top Industry Leader, a testament to his 30+ years leading teams and redefining the future of specialty medicine to help get ahead of disease. Congratulations, Court! #AheadTogether #GSKProud
GSK US tweet media
English
0
0
0
388
GSK US
GSK US@GSKUS·
Yesterday at #JPM2026: our CSO Tony Wood joined Endpoint News to share how our focused R&D approach – driven by science, advanced tech, and strategic partnerships – is accelerating pipeline momentum and our ambition to transform health. 🔗 Learn more: gsk.to/4qRrt6X
GSK US tweet media
English
0
0
0
515
GSK US
GSK US@GSKUS·
#News for #Media and #Investors: The US Food and Drug Administration (FDA) has approved our new, long-acting biologic therapy for people living with severe asthma. For more information, visit: gsk.to/457P6PZ
English
1
1
7
1.1K
GSK US
GSK US@GSKUS·
#News for #Investors and #Media: Today we announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline. Learn more here: gsk.to/4pynQma
English
1
1
3
617
GSK US
GSK US@GSKUS·
Big news for U.S. innovation! We've officially opened our new Vaccine & Infectious Disease R&D HQ in Boston's Cambridge Park Drive. This expanded space is central to our 5-year investment in the U.S., driving faster, better innovation for patients globally.
English
1
2
3
514
GSK US retweetledi
GSK
GSK@GSK·
Take a look at the highlights from our Q3 2025 performance 👇 More information for media and investors: gsk.to/3JzxOnq $GSK #Q3Results #Earnings
English
2
3
6
4K
GSK US retweetledi
GSK
GSK@GSK·
Today we announce our Q3 2025 results, with another quarter of strong performance and upgraded guidance for 2025. Hear more from our CEO Emma Walmsley ⤵️ More information for media and investors: gsk.to/4ns8cXo $GSK #Q3Results
English
2
3
7
2.6K
GSK US retweetledi
GSK
GSK@GSK·
Our Chief Digital & Technology Officer, Shobie Ramakrishnan, spoke at #BloombergTech this week about how an integrated use of tech across everything we do is helping us get ahead of disease. Here, Shobie shares why it's so critical to drive innovation - bringing science, tech and talent together to innovate in R&D 👇
Bloomberg Live@BloombergLive

"It takes over 10-12 years to bring a really big medicine to market - being able to change - by engineering biology - [will have] a massive impact on patients." @GSK's Shobie Ramakrishnan explores the intersection between tech and medicine at #BloombergTech.

English
0
3
4
3.6K